<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Received-in-Senate" bill-type="olc" dms-id="H4A518CB30A8545988CB8B67DF39077BC" key="G" public-private="public" stage-count="1"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 4439 : Creating Hope Reauthorization Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date></dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress display="yes">116th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 4439</legis-num><current-chamber display="yes">IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date>September 30 (legislative day, September 29), 2020</action-date><action-desc>Received</action-desc></action><legis-type>AN ACT</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.</official-title></form><legis-body id="H895630441D8D4ED3976F23CC30D1A40D" style="OLC"><section id="HB6540681162341D191350EC1EDE385DE" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Creating Hope Reauthorization Act</short-title></quote>.</text></section><section id="HBC12740769AE4328B681C37FB40B9274"><enum>2.</enum><header>Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases</header><text display-inline="no-display-inline">Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360ff">21 U.S.C. 360ff(b)(5)</external-xref>) is amended—</text><paragraph id="H2F3E41C1C6FB45B48ED10DC43ED132D9"><enum>(1)</enum><text>by striking <quote>December 11, 2020</quote> each place it appears and inserting <quote>September 30, 2024</quote>; and</text></paragraph><paragraph id="HAB8508B362FD46BEB402AE9D361AA46C"><enum>(2)</enum><text>in subparagraph (B), by striking <quote>December 11, 2022</quote> and inserting <quote>September 30, 2026</quote>.</text></paragraph></section></legis-body><attestation><attestation-group><attestation-date date="20200929" chamber="House">Passed the House of Representatives September 29, 2020.</attestation-date><attestor display="yes">Cheryl L. Johnson,</attestor><role>Clerk</role></attestation-group></attestation></bill> 

